Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy

Isr Med Assoc J. 2014 Dec;16(12):801-2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Anti-Bacterial Agents / administration & dosage
  • Antifungal Agents / administration & dosage
  • Ascites* / etiology
  • Ascites* / microbiology
  • Ascites* / therapy
  • Ascitic Fluid / microbiology*
  • Ascitic Fluid / pathology
  • Candida albicans / isolation & purification*
  • Ertapenem
  • Escherichia coli / isolation & purification
  • Escherichia coli / pathogenicity
  • Escherichia coli Infections / complications
  • Escherichia coli Infections / diagnosis
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / physiopathology
  • Fatal Outcome
  • Female
  • Fluconazole / administration & dosage*
  • Hepatic Encephalopathy / etiology*
  • Hepatitis C / complications
  • Humans
  • Liver Cirrhosis* / complications
  • Liver Cirrhosis* / diagnosis
  • Liver Cirrhosis* / microbiology
  • Liver Cirrhosis* / physiopathology
  • Middle Aged
  • Paracentesis / methods
  • Shock, Septic / etiology
  • beta-Lactams / administration & dosage

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • beta-Lactams
  • Fluconazole
  • Ertapenem